AN2 Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Eizen Joshua M | See Remarks | Sale | 2,819 | $1.14 | $3,214 | 177,353 | Nov 4, 2025 |
| Prior Stephen David | Chief Strategy Officer | Sale | 765 | $1.14 | $872 | 65,548 | Nov 4, 2025 |
| Marks Gilbert Lynn | — | Award / Grant | 10,367 | — | — | 63,749 | Oct 10, 2025 |
| Aziz Kabeer | — | Award / Grant | 10,367 | — | — | 40,919 | Oct 10, 2025 |
| Martin Patricia A. | — | Award / Grant | 3,274 | — | — | 13,255 | Oct 10, 2025 |
| Aziz Kabeer | — | Award / Grant | 11,875 | — | — | 30,552 | Jul 10, 2025 |
| Marks Gilbert Lynn | — | Award / Grant | 11,875 | — | — | 53,382 | Jul 10, 2025 |
| Martin Patricia A. | — | Award / Grant | 3,750 | — | — | 9,981 | Jul 10, 2025 |
| Easom Eric | Chief Executive Officer | Purchase | 10,000 | $1.07 | $10,700 | 256,380 | Jun 2, 2025 |
| Leonard Braden Michael | — | Sale | 425,000 | $1.01 | $429,250 | 3,224,432 | May 28, 2025 |
| FitzPatrick Margaret M | — | Purchase | 8,610 | $1.18 | $10,160 | 8,610 | May 28, 2025 |
| Leonard Braden Michael | — | Sale | 200,000 | $1.09 | $218,000 | 3,017,432 | May 28, 2025 |
| Zakrzewski Joseph S | — | Award / Grant | 10,523 | — | — | 145,538 | Apr 10, 2025 |
| Aziz Kabeer | — | Award / Grant | 9,705 | — | — | 18,677 | Apr 10, 2025 |
| Martin Patricia A. | — | Award / Grant | 3,065 | — | — | 6,231 | Apr 10, 2025 |
| Marks Gilbert Lynn | — | Award / Grant | 9,705 | — | — | 41,507 | Apr 10, 2025 |
| Chanda Sanjay | Chief Development Officer | Award / Grant | 50,250 | — | — | 80,074 | Feb 26, 2025 |
| Day Lucy | Chief Financial Officer | Award / Grant | 46,500 | — | — | 79,170 | Feb 26, 2025 |
| Eizen Joshua M | See Remarks | Award / Grant | 58,500 | — | — | 175,172 | Feb 26, 2025 |
| Easom Eric | Chief Executive Officer | Award / Grant | 145,250 | — | — | 246,380 | Feb 26, 2025 |
| Prior Stephen David | Chief Strategy Officer | Award / Grant | 28,000 | — | — | 61,313 | Feb 26, 2025 |
| Day Lucy | Chief Financial Officer | Sale | 2,957 | $1.34 | $3,962 | 32,670 | Jan 3, 2025 |
| Chanda Sanjay | Chief Development Officer | Sale | 2,957 | $1.34 | $3,962 | 29,824 | Jan 3, 2025 |
| Prior Stephen David | Chief Strategy Officer | Sale | 2,029 | $1.34 | $2,719 | 33,313 | Jan 3, 2025 |
| Eizen Joshua M | See Remarks | Sale | 9,663 | $1.34 | $12,948 | 116,672 | Jan 3, 2025 |
| Martin Patricia A. | — | Award / Grant | 3,166 | — | — | 3,166 | Dec 19, 2024 |
| Aziz Kabeer | — | Award / Grant | 8,972 | — | — | 8,972 | Dec 19, 2024 |
| Marks Gilbert Lynn | — | Award / Grant | 8,972 | — | — | 31,802 | Dec 19, 2024 |
| Zakrzewski Joseph S | — | Award / Grant | 9,816 | — | — | 135,015 | Dec 19, 2024 |
| Readnour Robin Shane | — | Award / Grant | 9,077 | — | — | 9,077 | Dec 19, 2024 |
| Readnour Robin Shane | — | Purchase | 5,000 | $1.49 | $7,450 | 582,288 | Dec 9, 2024 |
| Readnour Robin Shane | — | Purchase | 12,500 | $1.39 | $17,375 | 527,288 | Nov 27, 2024 |
| Zakrzewski Joseph S | — | Purchase | 2,000 | $1.40 | $2,800 | 125,199 | Nov 27, 2024 |
| Readnour Robin Shane | — | Purchase | 25,000 | $1.16 | $29,000 | 585,073 | Nov 20, 2024 |
| Zakrzewski Joseph S | — | Purchase | 20,000 | $1.00 | $20,000 | 118,199 | Nov 19, 2024 |
| Easom Eric | Chief Executive Officer | Purchase | 50,000 | $1.00 | $50,000 | 1,065,766 | Nov 18, 2024 |
| Prior Stephen David | Chief Strategy Officer | Award / Grant | 10,125 | — | — | 35,342 | Nov 4, 2024 |
| Eizen Joshua M | See Remarks | Award / Grant | 31,500 | — | — | 126,335 | Nov 4, 2024 |
| Leonard Braden Michael | — | Purchase | 1,500,000 | $1.04 | $1,560,000 | 5,749,432 | Aug 14, 2024 |
| RA Capital Healthcare Fund LP | — | Sale | 3,410,335 | $1.08 | $3,683,162 | 1,725,348 | Aug 9, 2024 |
| Eizen Joshua M | Chief Legal Officer | Award / Grant | 60,000 | — | — | 94,833 | Jul 10, 2024 |
| Eckburg Paul | Chief Medical Officer | Award / Grant | 30,000 | — | — | 51,416 | Mar 15, 2024 |
| Day Lucy | Chief Financial Officer | Award / Grant | 27,500 | — | — | 30,627 | Mar 15, 2024 |
| Eizen Joshua M | Chief Legal Officer | Award / Grant | 30,000 | — | — | 32,447 | Mar 15, 2024 |
| Krause Kevin Michael | Chief Strategy Officer | Award / Grant | 30,000 | — | — | 31,914 | Mar 15, 2024 |
| Chanda Sanjay | Chief Development Officer | Award / Grant | 27,500 | — | — | 28,235 | Mar 15, 2024 |
| Easom Eric | Chief Executive Officer | Award / Grant | 99,000 | — | — | 101,130 | Mar 15, 2024 |
| Day Lucy | Chief Financial Officer | Award / Grant | 27,500 | — | — | 30,627 | Mar 15, 2024 |
| Eizen Joshua M | Chief Legal Officer | Award / Grant | 30,000 | — | — | 32,447 | Mar 15, 2024 |
| Krause Kevin Michael | Chief Strategy Officer | Award / Grant | 30,000 | — | — | 31,914 | Mar 15, 2024 |